Geraldine O’Sullivan Coyne, MD, MRCPI, PhD

Geraldine O’Sullivan Coyne, MD, PhD, MRCPI, discusses how the START center may expand access to novel therapies for patients who reside in a community setting.

Geraldine O’Sullivan Coyne, MD, PhD, MRCPI, described the excitement of seeing novel molecules such as antibody-drug conjugates become more prominent.

Conducting trials safely within a community setting lies at the heart of a successful collaboration between Northwell Health and START.

The expertise of START's network may streamline the availability of clinical trial enrollment and novel treatment options among patients with cancer.

A new START center in New York may give patients with advanced malignancies an opportunity to access novel therapies in the community setting.

START is the largest early-phase oncology network in the community-based setting, according to Geraldine O’Sullivan Coyne, MD, PhD, MRCPI.